Physician

Naseem Eisa

According to 2025 Medicare claims, Naseem Eisa (NPI: 1659600112) practices internal medicine in the Fresno, CA market, with the plurality of this provider's patient population coming from Fresno, CA. This provider's primary affiliated billing organization is COMMUNITY HEALTH PARTNERS (NPI: 1952912420; TIN: 85-2103299) and primary practice location at 93720-3340.

Eisa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 850 traditional Medicare patients, billed 84,676 HCPCS/CPT codes, and received $1,134,927 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,280 prescription claims across 445 beneficiaries totaling $988,461 in drug costs, led by Ozempic (Semaglutide). DME data shows 118 claims. Open Payments data shows 26 records totaling $539. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $23,729 to $1,134,927. Similarly, Part D prescription costs have risen steadily, from $9,952 to $988,461. In contrast, DME billing represents a smaller volume and rose steadily, from $471 to $48,426.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	159	299	$23,729
2016	N/R	N/R	N/R
2017	106	1,686	$46,865
2018	298	6,444	$162,683
2019	463	12,299	$296,626
2020	626	22,866	$414,535
2021	779	21,671	$441,435
2022	847	26,042	$504,864
2023	872	60,294	$843,144
2024	850	84,676	$1,134,927

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	40	110	$9,952
2016	26	172	$45,249
2017	36	153	$26,489
2018	93	385	$180,520
2019	163	697	$272,278
2020	289	1,586	$662,974
2021	366	2,048	$834,928
2022	378	1,945	$759,472
2023	376	1,988	$905,691
2024	445	2,280	$988,461

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	14	$377
2017	N/R	11	$267
2018	37	79	$5,454
2019	32	92	$8,512
2020	97	325	$47,693
2021	105	599	$98,077
2022	75	426	$67,608
2023	52	274	$46,705
2024	40	118	$41,596

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	773	1,273	$95
77085	Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment	274	274	$57
77089	Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk	253	253	$32
J0897	Injection, denosumab, 1 mg	232	19,861	$21
96372	Injection of drug or substance under skin or into muscle	272	648	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	133	6,126	$196,575
Mounjaro	Tirzepatide	146	5,296	$185,330
Forteo	Teriparatide	25	756	$111,288
Teriparatide	Teriparatide	35	1,016	$105,544
Farxiga	Dapagliflozin Propanediol	38	2,801	$51,021

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	25	91	$41,146
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	15	27	$450

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$539	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Naseem Eisa?

Tedicare shows public-source Medicare data for Naseem Eisa (NPI 1659600112), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Naseem Eisa have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Naseem Eisa?

Naseem Eisa is linked to COMMUNITY HEALTH PARTNERS (billing NPI 1952912420) in the available physician profile data.

Does Naseem Eisa have Open Payments data?

Naseem Eisa has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.